INHIBITION OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS BY COBRA VENOM FACTOR
- 1 January 1982
- journal article
- research article
- Vol. 107 (1) , 25-28
Abstract
A single dose of cobra venom factor, a known potent depletor of serum complement, was recently reported to be highly effective in inhibiting lung collagen deposition [in rats] at 7 days after [the antineoplastic drug] bleomycin treatment. This, apparently, is associated with suppression of the bleomycin-induced increase in collagen synthesis , down to virtually normal levels. There is also a concomitant reduction in tissue-free proline pool size. No significant effects are noted in noncollagenous protein synthetic rates. This inhibitory effect is not seen at 30 days after bleomycin and is correlated with a return to normal levels of serum complement hemolytic activity. An important role for complement activity in the lungs fibrotic response to bleomycin was suggested.This publication has 18 references indexed in Scilit:
- THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN NEUTROPHIL-DEPLETED AND COMPLEMENT-DEPLETED RATS1981
- Effect of ethanol administration on free proline and glutamate in the intact rat liverBiochemical Pharmacology, 1980
- Bleomycin-induced Pulmonary Fibrosis in Rats: Biochemical Demonstration of Increased Rate of Collagen Synthesis1,2American Review of Respiratory Disease, 1980
- Modulation of delayed hypersensitivity in mice by cobra venom factorCellular Immunology, 1979
- BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN THE RAT - INHIBITION BY INDOMETHACIN1979
- Liver collagen synthesis in murine schistosomiasis.Journal of Clinical Investigation, 1977
- Interstitial Pneumonitis Associated with Bleomycin TherapyAmerican Journal of Clinical Pathology, 1972
- Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteinsBiochemistry, 1971
- Depletion of Plasma Complement in Vivo by a Protein of Cobra Venom: Its Effect on Various Immunologic ReactionsThe Journal of Immunology, 1970
- ON THE NATURE OF IMMUNOLOGICAL TOLERANCEThe Lancet, 1968